CN1449815A - Medicine for treating inflammation - Google Patents
Medicine for treating inflammation Download PDFInfo
- Publication number
- CN1449815A CN1449815A CN 03127008 CN03127008A CN1449815A CN 1449815 A CN1449815 A CN 1449815A CN 03127008 CN03127008 CN 03127008 CN 03127008 A CN03127008 A CN 03127008A CN 1449815 A CN1449815 A CN 1449815A
- Authority
- CN
- China
- Prior art keywords
- medicine
- isatidis
- radix
- flos lonicerae
- gypsum fibrosum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a Chinese medicine for curing various inflammations and virus infections, such as common cold, fever, sore-throat, parotitis, erysipelas, cerebritis and pneumonitis, etc. with obvious therapeutic effect. Said Chinese medicine is formed from isatis leaf, scutellaria root, lonicera flower, isatis root, gypsum and dandelion, and its total effective rate is up to 99.3%.
Description
Technical field
The present invention relates to a kind of medicine that is used for the treatment of inflammation, belong to the field of Chinese medicines.
Background technology
Various inflammation, viral infection as cold, fever, laryngopharynx swelling and pain, parotitis, erysipelas, encephalitis, pneumonia etc., belong to commonly encountered diseases, frequently-occurring disease.Medicine is a lot, but mostly exists certain not enough.Anaphylaxis often appears in Western medicine such as penicillin etc., and the human body Liver and kidney is diminished evil, uses inconvenient; Chinese medicine such as SHUANGHUANGLIAN KOUFUYE etc. are carried inconvenience, and be undesirable to the treatment of viral infections effect.
Summary of the invention
The purpose of this invention is to provide a kind of to inflammation, the more efficiently medicine that is used for the treatment of inflammation of treatment of viral infections effect.
The inventor is through research for many years, and the checking repeatedly by animal and clinical trial, selects to form medicine of the present invention by Chinese medicine coordinated such as Folium Isatidis, Radix Scutellariae, Flos Lonicerae, Radix Isatidis, Gypsum Fibrosum, Herba Taraxacis.
Medicine of the present invention is to be made by following bulk drugs:
Folium Isatidis 3-7 part, Radix Scutellariae 3-7 part, Flos Lonicerae 3-7 part, Radix Isatidis 3-7 part, Gypsum Fibrosum 7-13 part, Herba Taraxaci 7-13 part.
Be preferably: Folium Isatidis 4-6 part, Radix Scutellariae 4-6 part, Flos Lonicerae 4-6 part, Radix Isatidis 4-6 part, Gypsum Fibrosum 8-11 part, Herba Taraxaci 8-11 part.
Medicine of the present invention can adopt the conventional method of Chinese medicine preparation to be prepared into the oral preparations of any routine.
The preparation method of the active component of medicine of the present invention is as follows:
1, Radix Scutellariae, Radix Isatidis, the Herba Taraxaci of described weight proportion are selected totally, added and do not have the decocting of medicine to boil 2-3 time, each 1-3 hour, collecting decoction filtered, and filtrate concentrates, and is dried to dry extract;
2, Folium Isatidis, Flos Lonicerae, the Gypsum Fibrosum of described weight proportion are selected cleaning, mix oven dry thoroughly;
3,1 gained dry extract is mixed pulverizing with the Chinese medicine of 2 oven dry, cross 100 mesh sieves, just be prepared into the active component of medicine of the present invention.
The active component of medicine of the present invention can add preparation required various conventional adjuvant during different dosage form, is prepared into any peroral dosage form commonly used with the method for Chinese medicinal of routine, as pill, tablet, capsule, oral agents etc., especially tablet.
Medicine of the present invention is applicable to the various inflammation of treatment, viral infection, as cold, fever, laryngopharynx swelling and pain, parotitis, erysipelas, encephalitis, pneumonia etc.Have reasonable recipe, the pure natural Chinese herbal medicine, nontoxic to human body, therapeutic effect is remarkable, advantages such as short treating period.
The specific embodiment
Further describe beneficial effect of the present invention below by embodiment that provides and test example.
1, embodiment: the preparation of " the Dracocephalum moldabium plain sheet " of medicine of the present invention.
The weight proportion of embodiment 1-3 primary raw material sees the following form.Raw materials used medicine all should meet the regulation of Chinese Pharmacopoeia.
| Embodiment number | Folium Isatidis (kg) | Radix Scutellariae (kg) | Flos Lonicerae (kg) | Radix Isatidis (kg) | Gypsum Fibrosum (kg) | Herba Taraxaci (kg) |
| ????1 | ????3 | ????7 | ????3 | ????3 | ????7 | ????7 |
| ????2 | ????5 | ????6 | ????5 | ????4 | ????9 | ????10 |
| ????3 | ????7 | ????3 | ????7 | ????7 | ????13 | ????13 |
Preparation method is an example with embodiment 2:
(1) 6kg Radix Scutellariae, 4kg Radix Isatidis, 10kg Herba Taraxaci are selected totally, added the decocting that did not have medicine and boil 2 times, each 1 hour, collecting decoction filtered, and filtrate concentrates, and is dried to dry extract;
(2) 5kg Folium Isatidis, 5kg Flos Lonicerae, 9kg Gypsum Fibrosum are selected cleaning, mix oven dry thoroughly;
(3) dry extract is mixed pulverizing with the Chinese medicine of oven dry, cross 100 mesh sieves, get the Chinese medicine fine powder;
(4) the Chinese medicine fine powder is added excipient such as dextrin, starch, stir and make soft material, system granule, oven dry, granulate add lubricant tabletting, sugar coating, packing, packing, get Dracocephalum moldabium plain sheet.
Stipulate through every regulation and relevant quality standard that check embodiment 1-3 gained " Dracocephalum moldabium plain sheet " meets under the Chinese Pharmacopoeia tablet.
2, test example: the clinical observation report of the various inflammation of " Dracocephalum moldabium plain sheet " treatment
(1) case is selected: 600 routine patients, all derive from applicant outpatient, and wherein male 378 examples, women 222 examples are divided into two groups at random.
(2) diagnostic criteria: flu, heating, laryngopharynx swelling and pain, parotitis, erysipelas, encephalitis, pneumonia etc.
(3) Therapeutic Method:
A organizes (matched group) 300 examples, takes SHUANGHUANGLIAN KOUFUYE separately, 10 milliliters/, one time 1, day clothes 3 times, 7 days per courses of treatment.
B organizes (treatment group) 300 examples, oral Dracocephalum moldabium plain sheet, 0.5g/ sheet, a 1-4 sheet, warm water delivery service, day clothes 3 times, 24 hours per courses of treatment.
(4) curative effect determinate standard:
Cure: heating, pharyngalgia disappear.
Effectively: above-mentioned symptom obviously improves.
Invalid: above-mentioned symptom does not have improvement.
(5) therapeutic outcome:
| Matched group | Cure (%) | Effectively (%) | Invalid (%) | |
| First course of treatment | ????A | ??2(0.7) | ??268(89.3) | ????30(10.0) |
| ????B | ??3(1.0) | ??287(95.7) | ????10(3.3) | |
| Second course of treatment | ????A | ??156(52.0) | ??132(44.0) | ????12(4.0) |
| ????B | ??205(68.4) | ??88(29.3) | ????7(2.3) | |
| The 3rd course of treatment | ????A | ??210(70.0) | ??82(27.3) | ????8(2.7) |
| ????B | ??226(75.3) | ??72(24.0) | ????2(0.7) |
The A group compares P＜0.01 with B group total effective rate.
Clinical observation shows, uses the various inflammation of Drug therapy of the present invention, viral infection, as flu, heating, laryngopharynx swelling and pain, parotitis, erysipelas, encephalitis, pneumonia etc., except that 2 examples are used other treatment instead, all the other all obtained significant curative effect in 3 days, short treating period, and total effective rate reaches 99.3%.
Claims (4)
1, a kind of medicine that is used for the treatment of inflammation is characterized in that it is to be made by following bulk drugs:
Folium Isatidis 3-7 part, Radix Scutellariae 3-7 part, Flos Lonicerae 3-7 part, Radix Isatidis 3-7 part, Gypsum Fibrosum 7-13 part, Herba Taraxaci 7-13 part.
2, medicine according to claim 1 is characterized in that it is to be made by following raw medicaments in portion by weight:
Folium Isatidis 4-6 part, Radix Scutellariae 4-6 part, Flos Lonicerae 4-6 part, Radix Isatidis 4-6 part, Gypsum Fibrosum 8-11 part, Herba Taraxaci 8-11 part.
3, the preparation method of medicine as claimed in claim 1 is characterized in that it comprises the following steps:
(1) Radix Scutellariae, Radix Isatidis, the Herba Taraxaci of described weight proportion are selected totally, added and do not have the decocting of medicine to boil 2-3 time, each 1-3 hour, collecting decoction filtered, and filtrate concentrates, and is dried to dry extract;
(2) Folium Isatidis, Flos Lonicerae, the Gypsum Fibrosum of described weight proportion are selected cleaning, mix oven dry thoroughly;
(3) (1) gained dry extract is mixed pulverizing with the Chinese medicine of (2) oven dry, cross 100 mesh sieves, just be prepared into the active component of medicine of the present invention.
4,, it is characterized in that active component that step (3) is made and tablet adjuvant commonly used mixes tabletting according to the preparation method of the described medicine of claim 3.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031270085A CN1185005C (en) | 2003-04-26 | 2003-04-26 | Medicine for treating inflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031270085A CN1185005C (en) | 2003-04-26 | 2003-04-26 | Medicine for treating inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1449815A true CN1449815A (en) | 2003-10-22 |
| CN1185005C CN1185005C (en) | 2005-01-19 |
Family
ID=28684450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB031270085A Expired - Fee Related CN1185005C (en) | 2003-04-26 | 2003-04-26 | Medicine for treating inflammation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1185005C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102895373A (en) * | 2012-10-31 | 2013-01-30 | 顾宏斌 | Internal heat-reducing and inflammation-diminishing liquid formula |
| CN104998105A (en) * | 2015-07-08 | 2015-10-28 | 安徽老同桌生物科技有限公司 | Externally used traditional Chinese medicine for treating mump |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100473398C (en) * | 2003-12-19 | 2009-04-01 | 上海杏灵科技药业股份有限公司 | Chinese medicine preparation for treating respiratory tract infection and virus flu, preparing method thereof |
-
2003
- 2003-04-26 CN CNB031270085A patent/CN1185005C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102895373A (en) * | 2012-10-31 | 2013-01-30 | 顾宏斌 | Internal heat-reducing and inflammation-diminishing liquid formula |
| CN104998105A (en) * | 2015-07-08 | 2015-10-28 | 安徽老同桌生物科技有限公司 | Externally used traditional Chinese medicine for treating mump |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1185005C (en) | 2005-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100336546C (en) | Chinese medicinal preparation for treating gastroenteric disease | |
| CN1839952A (en) | Traditional Chinese medicine for treating rheumatic and rheumatoid arthritis | |
| CN1094055C (en) | Medicine for curing common cold and cough and its preparing process | |
| CN1872180A (en) | Medication of membranous milk vetch for activating blood and the channels, and preparation method | |
| CN101683420B (en) | Applications of traditional Chinese medicine composition in preparation of medicament for treating acute pharyngitis | |
| CN103055076B (en) | Pure Chinese medicinal composition for treating nosemosis of bees and preparation method of pure Chinese medicinal composition | |
| CN1185005C (en) | Medicine for treating inflammation | |
| CN1969940A (en) | Antivirus pharmaceutical composition | |
| CN1116049C (en) | Traditional Chinese medicine for curing non-gonococcal urethritis | |
| CN1170572C (en) | Medicine for treating atrophic gastritis and chronic colitis and preparation method thereof | |
| CN1111033C (en) | Psoriasis treating medicine | |
| CN1660377A (en) | Medication in use for treating inflammation | |
| CN1141966C (en) | Stone expelling medicine powder | |
| CN1185003C (en) | Medicine for promoting increase of bone substance | |
| CN1099876C (en) | Medicine for curing psoriasis | |
| CN1257732C (en) | Medicine for treating mastosis and preparation process thereof | |
| CN1141187A (en) | Medicine composition for curing cold | |
| CN1679715A (en) | Medicine for treating inflammation | |
| CN1272032C (en) | medicine for treating acute and chronic pharyngitis | |
| CN1340353A (en) | Orally-applied medicine for treating hepatism and its preparing process | |
| CN1814145A (en) | Chinese medicine composition for treating colpitis and use thereof | |
| CN1253195C (en) | Anti-age capsule of traditional Chinese medicine and preparation method | |
| CN1151803C (en) | Cancer treating Chinese medicine | |
| CN101181544B (en) | Medicament for curing category B icterus hepatitis and restraining hepatitis b virus | |
| CN1605355A (en) | Snuffle dredging capsule |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |